pH Pharma, bio venture, goes IPO onto KOSDAQ in the second half of this year

“Target to complete tech evaluation in first half… Expect licensing-out deal” Jaesik Kim, CEO, says

(For more information, please refer to the link below)

http://news.mt.co.kr/mtview.php?no=2019011514200854887&type=1